Skin Irritation Testing Services

Skin irritation testing encompasses a comprehensive suite of in vitro, ex vivo, and in vivo experimental approaches specifically designed to quantify the potential of chemical substances, cosmetic formulations, pharmaceutical products, or biological agents to induce reversible local inflammatory responses in mammalian skin. These characteristic inflammatory responses are defined by hallmark signs including erythema (visible skin redness), edema (tissue swelling), pruritus (itching sensations), or stinging, and they arise primarily from direct cytotoxicity to epidermal keratinocytes or disruption of the skin's stratum corneum barrier—distinct from immune-mediated allergic sensitization or irreversible corrosive tissue damage that causes permanent harm. At its core, this testing paradigm serves as a critical safety tool in preclinical research and product development, enabling scientists and researchers to systematically evaluate the safety profile of novel compounds, optimize formulations to minimize adverse skin effects, and generate reliable data to support mechanistic studies of skin-molecule interactions, which is essential for regulatory compliance and consumer safety.

Key Distinctions: Irritation vs. Sensitization vs. Corrosion

A precise understanding of the distinctions between skin irritation, sensitization, and corrosion is essential for designing targeted research testing strategies. These distinctions are quantified through distinct testing endpoints, ensuring that testing protocols are tailored to specific research questions. Detailed comparisons are summarized in the table below:

For research purposes, this differentiation ensures that testing protocols are tailored to the specific biological question—e.g., evaluating a novel cosmetic's irritancy potential versus studying a chemotherapeutic agent's corrosive effects on skin contact.

Our Services

CD BioSustainable offers a comprehensive portfolio of skin irritation testing services tailored exclusively to the needs of academic and industrial researchers engaged in preclinical development, mechanistic studies, and formulation optimization. Our services are designed to provide actionable, scientifically rigorous data that advance research objectives—from evaluating the irritancy of novel drug candidates to optimizing the safety profile of industrial chemicals or biobased materials. Leveraging state-of-the-art in vitro and ex vivo models, advanced analytical techniques, and a team of experienced toxicologists and tissue biologists, CD BioSustainable delivers reliable, reproducible results that support data-driven decision-making in research and development. Our services are applicable across multiple research domains, including pharmaceutical discovery (e.g., topical drug formulations), cosmetic science (e.g., novel ingredient testing), industrial chemistry (e.g., biocompatible material development), and environmental toxicology (e.g., assessing irritant potential of environmental contaminants).

In Vitro Reconstructed Human Epidermis (RhE) Irritation Testing

Our flagship in vitro RhE irritation testing service utilizes validated 3D reconstructed human epidermis models that recapitulate the biochemical and physiological properties of native human epidermis, including a fully differentiated stratum corneum, viable keratinocyte layers, and functional barrier function. This service is optimized for research applications, offering flexibility in exposure parameters (15–60 minutes of topical exposure, followed by 42–72 hours of post-exposure incubation) and endpoint measurements. Core endpoints include cell viability assessment via MTT assay (a colorimetric method that quantifies mitochondrial activity, with a viability ≤50% indicating irritant potential per OECD 439 criteria), barrier function evaluation via transepidermal water loss (TEWL) or skin impedance measurements, and inflammatory mediator quantification (IL-1α, TNF-α, IL-6) using ELISA or multiplex immunoassays. This service is ideal for high-throughput screening of novel compounds, formulation optimization studies (e.g., testing the impact of excipients on irritancy), and mechanistic research into irritant-induced barrier disruption. For example, we support pharmaceutical researchers in evaluating the irritancy of topical antibiotic formulations by testing multiple concentrations and measuring both cell viability and IL-1α release to identify the non-irritant dose range.

Ex Vivo Human/Animal Skin Irritation Testing

Our ex vivo skin irritation testing service leverages excised human skin (from surgical specimens) or animal skin (e.g., porcine, murine) to provide a more physiologically relevant model than in vitro RhE systems, particularly for studying substance penetration and tissue-level irritant effects. The service includes both acute and repeated exposure protocols, with customizable contact times (1–24 hours for acute, 2–4 weeks for repeated) and occlusive or non-occlusive application methods. Endpoints include macroscopic evaluation of erythema and edema (scored on a 0–4 scale), histopathological analysis (assessing epidermal thickness, inflammatory cell infiltration, and stratum corneum integrity via hematoxylin and eosin staining), and quantitative measurement of tissue viability and inflammatory mediators. This service is well-suited for research on substances with complex penetration profiles (e.g., nanoparticles, lipophilic compounds) and for validating in vitro results in a more intact tissue model. For instance, industrial chemistry researchers utilizing CD BioSustainable's services have employed ex vivo porcine skin testing to evaluate the irritant potential of biobased solvents, correlating histopathological findings (e.g., keratinocyte necrosis) with in vitro cell viability data to confirm irritant mechanisms.

Mechanistic Irritation Testing for Research Applications

Designed for researchers focused on understanding the molecular and cellular mechanisms underlying skin irritation, our mechanistic testing service combines irritation exposure with advanced analytical techniques to elucidate pathways such as oxidative stress, lipid peroxidation, and gene expression changes. Key endpoints include reactive oxygen species (ROS) quantification via DCFDA fluorescence assay, lipid composition analysis (ceramides, fatty acids) via HPLC-MS, and gene expression profiling (using qPCR or RNA sequencing) of barrier-related genes (e.g., filaggrin, claudin-1, involucrin) and inflammatory pathways. This service is fully customizable, allowing clients to target specific mechanisms of interest—e.g., investigating the role of ROS in surfactant-induced irritation or the impact of irritants on keratinocyte differentiation. For example, we collaborate with cosmetic science researchers to study the mechanistic effects of novel plant-derived ingredients, measuring ROS levels and filaggrin gene expression to determine if the ingredient mitigates irritant-induced barrier damage, supporting the development of "gentle" cosmetic formulations.

Acute and Cumulative Irritation Testing

Our acute and cumulative irritation testing services address the distinct research needs associated with single versus repeated exposure scenarios. Acute irritation testing evaluates the effects of a single, short-term exposure (typically 4 hours), simulating accidental contact or one-time product use, and includes endpoints such as immediate erythema/edema scoring and short-term cell viability. Cumulative irritation testing, by contrast, assesses the effects of repeated, low-dose exposure (e.g., daily application for 2–4 weeks), mimicking chronic product use (e.g., daily skincare products, industrial protective creams). Endpoints for cumulative testing include progressive erythema/edema scoring, cumulative irritation index calculation, barrier function recovery assessment, and histopathological evaluation of chronic inflammatory changes (e.g., dermal fibrosis). This service is critical for research on products intended for long-term use, enabling researchers to identify cumulative irritant thresholds and optimize formulations for chronic safety. CD BioSustainable's cumulative irritation testing has supported dermatological researchers in evaluating the safety of topical corticosteroid formulations, tracking barrier function recovery over 4 weeks to ensure the formulation does not induce persistent irritation with prolonged use.

Our Techniques

• 3D Reconstructed Human Epidermis (RhE) Model Technology
  The cornerstone of our in vitro testing capabilities, 3D RhE models are generated using primary human keratinocytes cultured at an air-liquid interface, allowing for full differentiation into a multi-layered epidermis with a functional stratum corneum—mimicking the barrier properties of native human skin.
• Molecular and Biochemical Analysis Technologies
  To support mechanistic research, CD BioSustainable employs a range of molecular and biochemical technologies to quantify irritant-induced changes at the cellular and molecular level. These include qPCR and RNA sequencing for gene expression profiling (e.g., barrier-related genes, inflammatory cytokines), HPLC-MS for lipid composition analysis (assessing stratum corneum lipid disruption), and ROS detection via DCFDA fluorescence assays (measuring oxidative stress).
• Histopathological and Imaging Techniques
  For ex vivo and in vivo research models, our testing relies on advanced histopathological and imaging techniques to visualize and quantify tissue-level irritant effects. Core technologies include brightfield microscopy for hematoxylin and eosin (H&E) stained sections, enabling the assessment of epidermal thickness, stratum corneum disruption, and inflammatory cell infiltration. Fluorescence microscopy, coupled with immunofluorescent staining (e.g., anti-keratin 10 for differentiated keratinocytes, anti-CD45 for immune cells), allows for targeted visualization of cell-specific damage. Confocal laser scanning microscopy (CLSM) provides 3D imaging of skin architecture, facilitating the study of irritant penetration depth and spatial distribution of inflammatory markers.

If you are interested in our services and products, please contact us for more information.

For Research or Industrial Raw Materials, Not For Personal Medical Use!